Dr. Mark A Rettenmaier MD Obstetrician-Gynecologist

Dr. Mark Rettenmaier is an obstetrician-gynecologist in Newport Beach, California. He is affiliated with multiple hospitals in the area, including Hoag Memorial Hospital Presbyterian and Pomona Valley Hospital Medical Center. He received his medical degree from University of Iowa Carver College of Medicine and has been in practice for 37 years. Dr. Rettenmaier accepts several types of health insurance, listed below. He is one of 82 doctors at Hoag Memorial Hospital Presbyterian and one of 43 at Pomona Valley Hospital Medical Center who specialize in Obstetrics & Gynecology.

Are you Dr. Mark Rettenmaier? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Obstetrician-Gynecologist: General Obstetrics & Gynecology

Hospital Affiliation

Hoag Memorial Hospital Presbyterian
High performing in Gynecology

Pomona Valley Hospital Medical Center

St. Joseph Hospital
High performing in Gynecology

St. Joseph Hospital
High performing in Gynecology

Education & Medical Training

University of California at Davis
Residency, Obstetrics and Gynecology, 1977 - 1981

University of Iowa Carver College of Medicine
Class of 1977

Certifications & Licensure

American Board of Pediatrics
Certified 21 years in Pediatrics

American Board of Pediatrics
Certified 8 years in Developmental-Behavioral Pediatrics

AZ State Medical License
Active through 2014

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services
2011

Publications & Presentations

Vorinostat is a potential precipitant for severe gastrointestinal toxicity.
Rettenmaier, M. A.,Wong, H.,Stone, M. K.,Bechtol, K.,Goldstein, B. H.

The Retreatment of Carboplatin via High Dose Intraperitoneal Chemotherapy in Patients with a History of a Hypersensitivity Reaction.
Rettenmaier, M. A.,Gray, C. M.,Lopez, K. L.,Bechtol, K. A.,Goldstein, B. H.

A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
Abaid, L. N.,Micha, J. P.,Rettenmaier, M. A.,Brown, J. V.,Mendivil, A. A.,Lopez, K. L.,Goldstein, B. H.

See all 101 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • Aetna Whole Health Banner Health Network
  • Anthem Blue Access PPO
  • Anthem Blue Preferred HMO
  • AvMed Health Open Access
  • BCBS Blue Card PPO
  • BCBS Illinois PPO
  • CIGNA HMO
  • CIGNA Open Access
  • CIGNA PPO
  • Cofinity PPO
  • Connecticare FlexPOS
  • Coventry Florida - Employer Group HMO/Open Access
  • Coventry Florida - Employer Group PPO
  • First Health PPO
  • GHI PPO
  • Great West PPO
  • Health Net Arizona HMO
  • Health Net Arizona PPO/POS
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Oxford Health Freedom
  • Oxford Health Liberty
  • Sagamore Health Plus
  • United - River Valley Neighborhood Health Partnership
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by

Specialty

Location

Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.